FCGR2B and monocytic leukemia: Due to the stronger inhibitory effect of IVIG on the activation of monocytes than that of T cells and patients’ different expressions of FcγR2B on monocytes, we investigated whether IVIG could regulate FcγR2B methylation in THP-1 cells (a human monocytic leukemia cell line) [7,22].